4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-064504
Chief Operations Officer sold 7,000 shares at an average $23.11 ($161,735)
- Chief Operations Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Operations Officer | 2020-12-16 | Option exercise | +3,500 | $12.15 | $42,525 | 120,055 | D |
| Newell Joe Chief Operations Officer | 2020-12-16 | Sale | −3,500 | $23.13 | $80,955 | 116,555 | D |
| Newell Joe Chief Operations Officer | 2020-12-16 | Sale | −3,500 | $23.08 | $80,780 | 113,055 | D |
| Derivatives | |||||||
| Newell Joe Chief Operations Officer | 2020-12-16 | Option exercise · Employee Stock Option (Right to Buy) | −3,146 | 49,187 | D | ||
| Newell Joe Chief Operations Officer | 2020-12-16 | Option exercise · Employee Stock Option (Right to Buy) | −354 | 13,813 | D | ||
| Open-market sales · 7,000 sh · avg $23.11 · $161,735 | |||||||
Loading xslF345X03/doc4.xml…